Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-06-07

Clinical Trial Update: Efficacy and Safety of Cilostazol in Patients of Vascular Cognitive Impairment-no Dementia (VCIND) [NA]

View source ↗

Summary

This clinical trial update discusses evaluating cilostazol for efficacy and safety in vascular cognitive impairment without dementia (VCIND), with mild cognitiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cilostazol (Cilostazol)

Snippet

Sponsor: Huashan Hospital | Conditions: Mild Cognitive Impairment | NA | Status: UNKNOWN